Sachin Dhawale | Medicinal Chemistry | Best Researcher Award

Assoc. Prof. Dr. Sachin Dhawale | Medicinal Chemistry | Best Researcher Award

Shreeyash Institute of Pharmaceutical Education and Research | India

Dr. Sachin Ashok Dhawale is a dedicated researcher in medicinal chemistry and pharmaceutical sciences, recognized for his contributions to drug design, molecular modeling, and synthetic chemistry. With a strong academic foundation including a PhD in Pharmacy, M.Pharm in Pharmaceutical Chemistry, and a B.Pharm degree, he has built extensive experience across academic and research environments, serving in teaching positions and contributing to funded research projects as a JRF and SRF under national scientific bodies. His scientific impact is reflected in 136 citations, an h-index of 6, and an i10-index of 4, supported by more than 25 Scopus-indexed publications, several as first or corresponding author, and cumulative impact exceeding 50. His research spans anticancer agents, antimicrobial molecules, molecular docking, natural product-based therapeutics, ADMET studies, and computational chemistry approaches. He has guided multiple undergraduate and postgraduate research projects, presented papers at national and international conferences, and published a specialized book on computer-aided drug design. His work has earned several recognitions including first-prize awards at competitive scientific events and fellowship support from national and state agencies. With expertise in advanced cheminformatics tools and synthetic techniques, he continues to contribute to innovative therapeutic discovery aimed at improving human health.

Profile: Google Scholar | Orcid

Featured Publications

Gandla, K., Islam, F., Zehravi, M., Karunakaran, A., Sharma, I., Haque, M. A., … Dhawale, S. A. (2023). Natural polymers as potential P-glycoprotein inhibitors: Pre-ADMET profile and computational analysis as a proof of concept to fight multidrug resistance in cancer. Heliyon, 9(9).

Singu, P. S., Kanugala, S., Dhawale, S. A., Kumar, C. G., & Kumbhare, R. M. (2020). Synthesis and pharmacological evaluation of some amide functionalized 1H-benzo[d]imidazole-2-thiol derivatives as antimicrobial agents. ChemistrySelect, 5(1), 117–123.

Dube, P. N., Sakle, N. S., Dhawale, S. A., More, S. A., & Mokale, S. N. (2019). Synthesis, biological investigation and docking study of novel chromen derivatives as anti-cancer agents. Anti-Cancer Agents in Medicinal Chemistry, 13.

Gawai, A. A., Kharat, A. R., Chorge, S. S., & Dhawale, S. A. (2023). Green synthesis of silver nanoparticles mediated Azadirachta indica extract and study of their characterization, molecular docking, and antibacterial activity. Journal of Molecular Recognition, 36(10), e3051.

Suryawanshi, R. M., Shimpi, R. B., Muralidharan, V., Nemade, L. S., Gurugubelli, S., … Dhawale, S. A. (2025). ADME, toxicity, molecular docking, molecular dynamics, glucokinase activation, DPP-IV, α-amylase, and α-glucosidase inhibition assays of mangiferin and friedelin for antidiabetic potential. Chemistry & Biodiversity, 22(5), e202402738.

Ankush Kumar | Medicinal Chemistry | Young Researcher Award

Mr. Ankush Kumar | Medicinal Chemistry | Young Researcher Award

Chitkara University Punjab | India

Ankush Kumar is a dedicated pharmaceutical researcher whose work spans medicinal chemistry, molecular modeling, and targeted drug design with a strong focus on anticancer therapeutics. He holds a solid academic foundation with qualifications in pharmaceutical chemistry and extensive research training that includes computational drug design, structure-activity exploration, and medicinal insights into heterocyclic scaffolds. His professional experience includes serving as a Junior Research Fellow and working as an Assistant Professor across multiple academic institutions, where he contributed to teaching, mentoring, and research development. His research outputs reflect a strong contribution to oncology-oriented drug discovery, with publications covering molecular targets, biomarkers, EGFR inhibition, heterocyclic synthesis, and computational repurposing studies. He has authored numerous research papers in reputed journals, contributing to a total of 561 citations, supported by an h-index of 6 and i10-index of 4, demonstrating the growing influence of his scientific contributions. His work includes book chapters and multiple peer-reviewed articles that highlight new therapeutic strategies and structural insights into various biological targets. He has received academic distinctions such as top positions in academic competitions and has served as a reviewer for international journals, further reflecting his scholarly engagement. Overall, his research trajectory reflects a commitment to advancing pharmaceutical innovation and precision-driven drug discovery.

Profile: Google Scholar

Featured Publications

Ye, F., Dewanjee, S., Li, Y., Jha, N. K., Chen, Z. S., Kumar, A., Vishakha, Jha, S. K., et al. (2023). Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer. Molecular Cancer, 22(1), 105.

Kumar, A., Sehgal, A., Singh, S., Sharma, N., Yadav, S., Rashid, S., Ali, N., et al. (2023). Understanding the mechanistic pathways and clinical aspects associated with protein and gene based biomarkers in breast cancer. International Journal of Biological Macromolecules, Article 126595.

Zheng, M., Kumar, A., Sharma, V., Sehgal, A., Wal, P., Shinde, N. V., Kawaduji, B. S., et al. (2024). Revolutionizing pediatric neuroblastoma treatment: unraveling new molecular targets for precision interventions. Frontiers in Cell and Developmental Biology, 12, Article 1353860.

Kumar, A., Kumar, B., & Bhatia, R. (2023). Design, synthesis, molecular docking, and biological evaluation of isatin-based fused heterocycles as epidermal growth factor receptor inhibitors. Assay and Drug Development Technologies, 21(5), 222–233.

Kumar, A., Narang, R. K., & Bhatia, R. (2023). Recent advancements in NS5B inhibitors (2011–2021): Structural insights, SAR studies and clinical status. Journal of Molecular Structure, 1293, Article 136272.

Ruby Anto | Cancer | Best Researcher Award

Dr. Ruby Anto | Cancer | Best Researcher Award

Centre of Excellence in Nutraceuticals, Government of Kerala | India

Dr. Ruby John Anto is a distinguished biomedical scientist whose pioneering research has significantly advanced the field of cancer biology and nutraceutical sciences. She holds a Ph.D. in Biochemistry from Amala Cancer Research Centre, Thrissur, and has served in various scientific capacities at the Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, including Scientist G, before taking up her current role as Chief Scientist at the Centre of Excellence in Nutraceuticals under KSCSTE, Government of Kerala, and Honorary Scientist at the Institute of Advanced Virology. Her research focuses on the bioprospecting of natural compounds with therapeutic potential against cancer, inflammation, and lifestyle diseases. A highlight of her work is the discovery of Uttroside B, a potent anticancer compound that earned “Orphan Drug” designation from the US FDA for liver cancer treatment and is patented internationally. With an h-index of 42, i10-index of 63, and over 7,600 citations from 80+ international publications, Dr. Anto’s work has received widespread recognition. She has been honored with national and international awards, including the National Woman Bio-Scientist Award and the Keystone Symposia Global Health Award. Her scientific leadership continues to inspire innovation in cancer research, nutraceuticals, and translational medicine.

Profiles: Google Scholar | Scopus

Featured Publications

Ruby, A. J., Kuttan, G., Babu, K. D., Rajasekharan, K. N., & Kuttan, R. (1995). Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Letters, 94(1), 79–83. https://doi.org/ (Cited by: 1571)

Anto, R. J., Mukhopadhyay, A., Denning, K., & Aggarwal, B. B. (2002). Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: Its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis, 23(1), 143–150. https://doi.org/ (Cited by: 593)

Anto, R. J., Sukumaran, K., Kuttan, G., Rao, M. N. A., Subbaraju, V., & Kuttan, R. (1995). Anticancer and antioxidant activity of synthetic chalcones and related compounds. Cancer Letters, 97(1), 33–37. https://doi.org/ (Cited by: 456)

Oommen, S., Anto, R. J., Srinivas, G., & Karunagaran, D. (2004). Allicin (from garlic) induces caspase-mediated apoptosis in cancer cells. European Journal of Pharmacology, 485(1–3), 97–103. https://doi.org/ (Cited by: 393)

Anto, R. J., Mukhopadhyay, A., Shishodia, S., Gairola, C. G., & Aggarwal, B. B. (2002). Cigarette smoke condensate activates nuclear transcription factor-κB through phosphorylation and degradation of IκBα: Correlation with induction of cyclooxygenase-2. Carcinogenesis, 23(9), 1511–1518. https://doi.org/ (Cited by: 335)

Sandeep Pandey | Oncology | Best Researcher Award

Dr. Sandeep Pandey | Oncology | Best Researcher Award

King George’s Medical University | India

Sandeep Pandey is a dedicated researcher in molecular cancer biology, currently pursuing a PhD in Biochemistry at King George’s Medical University, Lucknow. He works as a Senior Research Fellow in the Department of Biochemistry and Hemato-Pathology, focusing on the molecular mechanisms underlying leukemia. His academic journey reflects a deep interest in biochemistry, molecular biology, and cancer therapeutics. Alongside his research, he has contributed to teaching and mentoring students in biology and zoology. With multiple publications, conference presentations, and active involvement in professional societies, he continues to advance his expertise in molecular diagnostics and translational cancer research.

Professional Profile

Google Scholar

Education

Sandeep Pandey has built a strong academic foundation in life sciences through progressive studies in biochemistry and related disciplines. He earned his undergraduate degree in Chemistry, Zoology, and Botany, followed by a postgraduate degree in Biochemistry, where he conducted research on recombinant enzyme expression and purification. His academic training also included hands-on work in molecular biology laboratories, fostering expertise in protein studies and genetic techniques. Currently, he is pursuing doctoral research in Biochemistry at King George’s Medical University, focusing on cancer biology and molecular diagnostics. His educational background reflects a blend of theoretical understanding and practical laboratory experience.

Professional Experience

Sandeep Pandey has substantial experience in research, particularly in molecular cancer biology, with a focus on leukemia. He has served as a Junior and Senior Research Fellow at King George’s Medical University, working extensively on cell culture, gene expression analysis, and molecular diagnostic techniques. His professional journey also includes work as a Clinical Research Coordinator for a cancer drug trial, contributing to translational oncology studies. In addition, he has been a graduate trainee at a premier research institute, where he worked on molecular cloning and protein purification. His experience extends to part-time teaching, training students for academic and competitive examinations.

Awards and Recognition

Sandeep Pandey has received notable recognition for his academic and research contributions. He was awarded a Senior Research Fellowship by the Indian Council of Medical Research for his work on leukemia and qualified the GATE examination in life sciences. His research presentations at conferences have earned accolades, including a first prize for best oral presentation. He has been invited as a reviewer for reputed scientific journals and holds lifetime memberships in professional societies such as the Indian Society of Oncology and the Indian Science Congress. His achievements reflect a commitment to advancing scientific knowledge and contributing to the research community.

Research Skills

Sandeep Pandey possesses a diverse set of research skills covering cell culture, molecular biology, bioinformatics, and in vivo studies. His expertise includes maintaining and analyzing cell lines, performing flow cytometry, gene knockdown techniques, PCR, Western blotting, ELISA, and fluorescence microscopy. He is proficient in genomic and proteomic analysis, animal handling for research, and data interpretation using specialized software. His skills extend to both experimental design and execution, with an emphasis on cancer biology and diagnostics. Additionally, he has experience in collaborative, multidisciplinary research environments, integrating laboratory findings with clinical applications for better understanding and treatment of diseases.

Notable Publications

Regulation of hypoxia dependent reprogramming of cancer metabolism: Role of hif-1 and its potential therapeutic implications in leukemia
Author: S Pandey, R Singh, N Habib, RM Tripathi, R Kushwaha, AA Mahdi
Journal: Asian Pacific Journal of Cancer Prevention: APJCP 25 (4), 1121
Year: 2024
Citations: 5

Expression of CXCL8 (IL-8) in the pathogenesis of T-cell acute lymphoblastic leukemia patients
Author: S Pandey, R Singh, N Habib, V Singh, R Kushwaha, AK Tripathi, …
Journal: Cureus 15 (9)
Year: 2023
Citations: 4

Correlation between salivary cortisol levels and diurnal variation in spirometric parameters in apparently healthy adults
Author: T Mathur, YR Annepu, PDK Chaitanya, R Ranjan, DK Verma, N Verma, …
Journal: Cureus 16 (10)
Year: 2024
Citations: 2

Concerns for human health relating to methylmercury (MeHg) toxicity in aquatic environment: a systematic literature review
Author: RM Tripathi, S Pandey, AA Mahdi, M Serajuddin, K Singh, M Kaleem
Journal: Journal of Advanced Zoology
Year: 2023
Citations: 2

Osteoporosis, Its Pathophysiology and Effect of Nutraceuticals.
Author: Z Ara, S Pandey, S Pant, RM Tripathi, D Rastogi, S Waliullah
Journal: Indian Journal of Public Health Research & Development 14 (3)
Year: 2023
Citations: 1

Conclusion

Sandeep Pandey’s professional journey reflects a consistent dedication to research, academic growth, and knowledge dissemination in the fields of biochemistry and molecular cancer biology. His expertise spans laboratory techniques, clinical research, and academic teaching, enabling him to contribute to both fundamental and applied sciences. With numerous publications, conference presentations, and active participation in professional bodies, he continues to expand his scientific horizons. His work demonstrates a strong commitment to advancing cancer research, improving diagnostic tools, and exploring novel therapeutic approaches. Through his academic and professional efforts, he aims to contribute meaningfully to biomedical sciences and healthcare innovation.